HIGHMARK COMMERCIAL MEDICAL POLICY - PENNSYLVANIA

 
 

Medical Policy:
E-7-031
Topic:
Pneumatic Compression Devices
Section:
Durable Medical Equipment
Effective Date:
February 12, 2023
Issued Date:
February 12, 2023
Last Revision Date:
December 2022
Annual Review:
December 2022
 
 

A pneumatic compression therapy device functions as a pump to improve circulation. The device consists of an inflatable garment, usually for the arm, leg, and/or ankle, and an electric pump. The inflatable garment is intermittently inflated and deflated in a cycle of time and pressure. Pneumatic compression therapy devices are classified as non-segmented or segmented, with or without calibrated gradient pressure.

Policy Position

Pneumatic compression devices/lymphedema pumps and appliances for in-home use may be considered medically necessary when ALL of the following are met:

  • When prescribed by a physician; and
  • Has appropriate physician oversight (i.e., physician evaluation of the individual’s condition to determine medical necessity of the device, suitable instruction in the operation of the machine as to the pressure to be used and the frequency and duration of use, and ongoing monitoring of use and response to treatment).

Segmented or non-segmented pneumatic compression devices without calibrated gradient pressure for in-home use may be considered medically necessary for the treatment of ANY ONE of the following:

  • Lymphedema treatment (pumps and appliances) of the arm or leg that has failed a four (4) week trial of conservative therapy and the treating physician determines that there has been no significant improvement or if significant symptoms remain after the trial. The trial of conservative therapy must include ALL of the following:
    • A compression bandage system or compression garment; and
    • Exercise; and
    • Elevation of the limb.

OR

  • Chronic venous insufficiency (CVI) of the lower extremities with non-healing venous stasis ulcer(s) after a six (6) month trial of conservative therapy directed by the treating physician. The trial of conservative therapy must include ALL of the following:
    • A compression bandage system or compression garment; and
    • Appropriate dressings for the wound; and
    • Exercise; and
    • Elevation of the limb.

OR

In-home use of limb compression devices for the following indications may be considered medically necessary for ANY ONE of the following:

  • Prevention of post-thrombotic syndrome; or
  • Venous thromboembolism (VTE) prophylaxis after major orthopedic surgery (e.g. total hip arthroplasty, total knee arthroplasty, hip fracture surgery) in individuals with a contraindication to pharmacological agents, i.e., at high risk for bleeding; or
  • VTE prophylaxis after major non-orthopedic surgery or non-major orthopedic surgery in patients who are at moderate or high risk of VTE (see Professional Statements and Societal Positions) with a contraindication to pharmacological agents, i.e., at high risk for bleeding.

In-home use of limb compression devices for VTE prophylaxis for the following conditions, are considered experimental/investigational and, therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature:

  • After major orthopedic surgery for individuals without a contraindication to pharmacological prophylaxis; or
  • After major non-orthopedic surgery or non-major orthopedic surgery, for individuals who are at moderate or high risk of VTE without a contraindication to pharmacological prophylaxis and in patients who are at low risk of VTE; or
  • After all other surgeries.

A portable, intermittent, limb compression device (i.e. Vena Pro) is considered experimental/ investigational and, therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature.

 In-home use of limb compression devices for VTE prophylaxis for periods longer than 30 days post-surgery is not medically necessary.

Pneumatic compression devices not meeting the criteria as indicated in this policy are considered not medically necessary. 

E0650

E0651

E0652

E0655

E0660

E0665

E0666

E0667

E0668

E0669

E0671

E0672

E0673

E0676

E1399

 

 

 

 

 

 




Segmented pneumatic compression therapy devices with calibrated gradient pressure may be considered medically necessary for in-home use when the following medical necessity criteria are met:

  • The individual's medical condition has failed to respond to therapy using a segmented pneumatic compressor without calibrated gradient pressure with clear documentation that the individual has unique characteristics that prevent satisfactory pneumatic compression treatment using a non-segmented device with a segmented appliance/sleeve or a segmented device without manual control of the pressure in each chamber.

Segmented pneumatic compression therapy devices with calibrated gradient pressure not meeting the criteria as indicated in this policy are considered not medically necessary.  

E0652

E0671

E0672

E0673

 

 

 




The use of pneumatic compression devices for the treatment of lymphedema of the head, neck, chest or trunk, and/or the treatment of arterial insufficiency, is considered experimental/investigational and, therefore, non-covered because the safety and/or effectiveness of this service cannot be established by the available published peer-reviewed literature.

E0656

E0657

E0670

E0675

E1399

 

 




Professional Statements and Societal Positions Guidelines

Guidance on Determining High Risk for Bleeding

American College of Chest Physicians (ACCP) 2012 guidelines on prevention of VTE in orthopedic surgery patients list the following general risk factors for bleeding:

  • Previous major bleeding (and previous bleeding risk similar to current risk)
  • Severe renal failure
  • Concomitant antiplatelet agent
  • Surgical factors: history of or difficult-to-control surgical bleeding during the current operative procedure, extensive surgical dissection, and revision surgery

The guidelines note, however, that “specific thresholds for using mechanical compression devices or no prophylaxis instead of anticoagulant thromboprophylaxis have not been established.”

Guidance on Risk Level for Patients Undergoing Non-orthopedic Surgery

The 2012 ACCP guidelines on prevention of VTE in non-orthopedic surgery patients included the following discussion of risk levels: “In patients undergoing general and abdominal-pelvic surgery, the risk of VTE varies depending on both patient-specific and procedure-specific factors. Examples of relatively low-risk procedures include laparoscopic cholecystectomy, appendectomy, transurethral prostatectomy, inguinal herniorrhaphy, and unilateral or bilateral mastectomy. Open-abdominal and open-pelvic procedures are associated with a higher risk of VTE. VTE risk appears to be highest for patients undergoing abdominal or pelvic surgery for cancer…”

“Independent risk factors include age at least 60 years, prior VTE, and cancer; age greater than or equal to 60 years, prior VTE, anesthesia greater than or equal to 2 hours, and bed rest greater than or equal to 4 days; older age, male sex, longer length of hospital stay, and higher Charlson comorbidity score; and sepsis, pregnancy or postpartum state, central venous access, malignancy, prior VTE, and inpatient hospital stay more than 2 days. In another study, most of the moderate to strong independent risk factors for VTE were surgical complications, including urinary tract infection, acute renal insufficiency, postoperative transfusion, perioperative myocardial infarction, and pneumonia”.

The American College of Obstetricians and Gynecologists (ACOG, 2007, reaffirmed 2021) proposed the following risk classification for VTE in patients undergoing major gynecological surgery:

  • Low: Surgery lasting less than 30 minutes in patients younger than 40 years with no additional risk factors.
  • Moderate: Surgery lasting less than 30 minutes in patients with additional risk factors; surgery lasting less than 30 minutes in patients age 40 to 60 years with no additional risk factors; major surgery in patients younger than 40 years with no additional risk factors.
  • High: Surgery lasting less than 30 minutes in patients older than 60 years or with additional risk factors; major surgery in patients older than 40 years or with additional risk factors.
  • Highest: Major surgery in patients older than 60 years plus prior venous thromboembolism, cancer, or molecular hypercoagulable state.

American Society of Clinical Oncology (ASCO) – 2019

Guidance for Individuals with Cancer

In 2019, the American Society of Clinical Oncology (ASCO) released updates to the clinical practice guideline on VTE prophylaxis and treatment in patients with cancer. The guideline makes the following recommendation for mechanical prophylaxis in this patient population:

  • "Mechanical methods may be added to pharmacologic thromboprophylaxis but should not be used as monotherapy for VTE prevention unless pharmacologic methods are contraindicated because of active bleeding or high bleeding risk."
  • "A combined regimen of pharmacologic and mechanical prophylaxis may improve efficacy, especially in the highest-risk patients."


COVERED DIAGNOSIS CODES FOR PROCEDURE CODES; E0650, E0651, E0652, E0655, E0660, E0665, E0666, E0667, E0668, E0669, E0671, E0672, E0673

 

I87.011

I87.012

I87.013

I87.021

I87.022

I87.023

I87.031

I87.032

I87.033

I87.091

I87.092

I87.093

I87.2

I89.0

I97.2

L97.111

L97.112

L97.113

L97.114

L97.115

L97.116

L97.118

L97.119

L97.121

L97.122

L97.123

L97.124

L97.125

L97.126

L97.128

L97.129

L97.211

L97.212

L97.213

L97.214

L97.215

L97.216

L97.218

L97.219

L97.221

L97.222

L97.223

L97.224

L97.225

L97.226

L97.228

L97.229

L97.311

L97.312

L97.313

L97.314

L97.315

L97.316

L97.318

L97.319

L97.321

L97.322

L97.323

L97.324

L97.325

L97.326

L97.328

L97.329

L97.411

L97.412

L97.413

L97.414

L97.415

L97.416

L97.418

L97.419

L97.421

L97.422

L97.423

L97.424

L97.425

L97.426

L97.428

L97.429

L97.505

L97.506

L97.508

L97.511

L97.512

L97.513

L97.514

L97.515

L97.516

L97.518

L97.519

L97.521

L97.522

L97.523

L97.524

L97.525

L97.526

L97.528

L97.529

L97.811

L97.812

L97.813

L97.814

L97.815

L97.816

L97.818

L97.819

L97.821

L97.822

L97.823

L97.824

L97.825

L97.826

L97.828

L97.829

L97.911

L97.912

L97.913

L97.914

L97.915

L97.916

L97.918

L97.919

L97.921

L97.922

L97.923

L97.924

L97.925

L97.926

L97.928

L97.929

L98.415

L98.416

L98.418

L98.425

L98.426

L98.428

L98.495

L98.496

L98.498

Q82.0



Place of Service: Outpatient

Experimental/Investigational (E/I) services are not covered regardless of place of service.

Pneumatic Compression Devices are typically an outpatient service which is only eligible for coverage as an inpatient service in special circumstances including, but not limited to the presence of a co-morbid condition that would require monitoring in a more controlled environment such as the inpatient setting.



The policy position applies to all commercial lines of business



Links






This policy is designed to address medical guidelines that are appropriate for the majority of individuals with a particular disease, illness, or condition. Each person's unique clinical or other circumstances may warrant individual consideration, based on review of applicable medical records, as well as other regulatory, contractual and/or legal requirements.

Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect Highmark's reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Highmark retains the right to review and update its medical policy guidelines at its sole discretion. These guidelines are the proprietary information of Highmark. Any sale, copying or dissemination of the medical policies is prohibited; however, limited copying of medical policies is permitted for individual use.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
    • Qualified sign language interpreters
    • Written information in other formats (large print, audio, accessible electronic formats, other formats)
  • Provides free language services to people whose primary language is not English, such as:
    • Qualified interpreters
    • Information written in other languages

If you need these services, contact the Civil Rights Coordinator.

If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295, TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

U.S. Department of Health and Human Services
200 Independence Avenue, SW
Room 509F, HHH Building
Washington, D.C. 20201
1-800-368-1019, 800-537-7697 (TDD)

Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.

This information is issued by Highmark Blue Shield on behalf of its affiliated Blue companies, which are independent licensees of the Blue Cross Blue Shield Association.  Highmark Inc. d/b/a Highmark Blue Shield and certain of its affiliated Blue companies serve Blue Shield members in the 21 counties of central Pennsylvania. As a partner in joint operating agreements, Highmark Blue Shield also provides services in conjunction with a separate health plan in southeastern Pennsylvania.  Highmark Inc. or certain of its affiliated Blue companies also serve Blue Cross Blue Shield members in 29 counties in western Pennsylvania, 13 counties in northeastern Pennsylvania, the state of West Virginia plus Washington County, Ohio, the state of Delaware[ and [8] counties in western New York and Blue Shield members in [13] counties in northeastern New York].  All references to Highmark in this document are references to Highmark Inc. d/b/a Highmark Blue Shield and/or to one or more of its affiliated Blue companies.





Medical policies do not constitute medical advice, nor are they intended to govern the practice of medicine. They are intended to reflect reimbursement and coverage guidelines. Coverage for services may vary for individual members, based on the terms of the benefit contract.

Discrimination is Against the Law
The Claims Administrator/Insurer complies with applicable Federal civil rights laws and does not discriminate on the basis of race, color, national origin, age, disability, or sex. The Claims Administrator/Insurer does not exclude people or treat them differently because of race, color, national origin, age, disability, or sex. The Claims Administrator/ Insurer:

  • Provides free aids and services to people with disabilities to communicate effectively with us, such as:
  • Qualified sign language interpreters
  • Written information in other formats (large print, audio, accessible electronic formats, other formats)

  • Provides free language services to people whose primary language is not English, such as:
  • Qualified interpreters
  • Information written in other languages
  • If you need these services, contact the Civil Rights Coordinator.

    If you believe that the Claims Administrator/Insurer has failed to provide these services or discriminated in another way on the basis of race, color, national origin, age, disability, or sex, you can file a grievance with: Civil Rights Coordinator, P.O. Box 22492, Pittsburgh, PA 15222, Phone: 1-866-286-8295 , TTY: 711, Fax: 412-544-2475, email: CivilRightsCoordinator@highmarkhealth.org. You can file a grievance in person or by mail, fax, or email. If you need help filing a grievance, the Civil Rights Coordinator is available to help you.

    You can also file a civil rights complaint with the U.S. Department of Health and Human Services, Office for Civil Rights electronically through the Office for Civil Rights Complaint Portal, available at https://ocrportal.hhs.gov/ocr/portal/lobby.jsf, or by mail or phone at:

    U.S. Department of Health and Human Services
    200 Independence Avenue, SW
    Room 509F, HHH Building
    Washington, D.C. 20201
    1-800-368-1019, 800-537-7697 (TDD)

    Complaint forms are available at http://www.hhs.gov/ocr/office/file/index.html.